A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Clinical trial NCT05458219 · RECRUITING
Trial details
- NCT number
- NCT05458219
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2027-06-30
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.